106 related articles for article (PubMed ID: 2731406)
1. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
Dahl-Puustinen ML; Perry TL; Dumont E; von Bahr C; Nordin C; Bertilsson L
Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline.
Dahl ML; Nordin C; Bertilsson L
Ther Drug Monit; 1991 May; 13(3):189-94. PubMed ID: 1926270
[TBL] [Abstract][Full Text] [Related]
3. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
[TBL] [Abstract][Full Text] [Related]
4. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
[TBL] [Abstract][Full Text] [Related]
5. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
Nordin C; Bertilsson L
Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in human and rat liver microsomes.
Dumont E; von Bahr C; Perry TL; Bertilsson L
Pharmacol Toxicol; 1987 Nov; 61(5):335-41. PubMed ID: 3125532
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
[TBL] [Abstract][Full Text] [Related]
8. Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
Otani K; Kaneko S; Bertilsson L
Pharmacol Toxicol; 1991 May; 68(5):380-3. PubMed ID: 1946183
[TBL] [Abstract][Full Text] [Related]
9. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine.
Pfandl B; Mörike K; Winne D; Schareck W; Breyer-Pfaff U
Xenobiotica; 1992 Jun; 22(6):721-30. PubMed ID: 1441595
[TBL] [Abstract][Full Text] [Related]
11. Plasma 10-hydroxynortriptyline in elderly depressed patients.
Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
[TBL] [Abstract][Full Text] [Related]
12. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
Dahl ML; Bertilsson L; Nordin C
Psychopharmacology (Berl); 1996 Feb; 123(4):315-9. PubMed ID: 8867869
[TBL] [Abstract][Full Text] [Related]
13. Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects.
Nordin C; Bertilsson L; Otani K; Widmark A
Clin Pharmacol Ther; 1987 Jan; 41(1):97-102. PubMed ID: 3802713
[TBL] [Abstract][Full Text] [Related]
14. 10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.
Dalén P; Dahl ML; Bernal Ruiz ML; Nordin J; Bertilsson L
Clin Pharmacol Ther; 1998 Apr; 63(4):444-52. PubMed ID: 9585799
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
Nordin C; Bertilsson L; Siwers B
Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.
Pollock BG; Everett G; Perel JM
Neuropsychopharmacology; 1992 Jan; 6(1):1-10. PubMed ID: 1571065
[TBL] [Abstract][Full Text] [Related]
17. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
[TBL] [Abstract][Full Text] [Related]
18. CSF/plasma ratio of 10-hydroxynortriptyline is influenced by sex and body height.
Nordin C
Psychopharmacology (Berl); 1993; 113(2):222-4. PubMed ID: 7855185
[TBL] [Abstract][Full Text] [Related]
19. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
[TBL] [Abstract][Full Text] [Related]
20. Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings.
Dahl-Puustinen ML; Lidén A; Alm C; Nordin C; Bertilsson L
Clin Pharmacol Ther; 1989 Jul; 46(1):78-81. PubMed ID: 2743709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
